272 related articles for article (PubMed ID: 20719947)
21. Identification of RNF168 as a PML nuclear body regulator.
Shire K; Wong AI; Tatham MH; Anderson OF; Ripsman D; Gulstene S; Moffat J; Hay RT; Frappier L
J Cell Sci; 2016 Feb; 129(3):580-91. PubMed ID: 26675234
[TBL] [Abstract][Full Text] [Related]
22. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
23. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.
Saridakis V; Sheng Y; Sarkari F; Holowaty MN; Shire K; Nguyen T; Zhang RG; Liao J; Lee W; Edwards AM; Arrowsmith CH; Frappier L
Mol Cell; 2005 Apr; 18(1):25-36. PubMed ID: 15808506
[TBL] [Abstract][Full Text] [Related]
24. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
25. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.
Malik-Soni N; Frappier L
J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234
[TBL] [Abstract][Full Text] [Related]
26. The alphaherpesvirus serine/threonine kinase us3 disrupts promyelocytic leukemia protein nuclear bodies.
Jung M; Finnen RL; Neron CE; Banfield BW
J Virol; 2011 Jun; 85(11):5301-11. PubMed ID: 21430051
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells.
Wang L; Tian WD; Xu X; Nie B; Lu J; Liu X; Zhang B; Dong Q; Sunwoo JB; Li G; Li XP
Cancer; 2014 Feb; 120(3):363-72. PubMed ID: 24190575
[TBL] [Abstract][Full Text] [Related]
28. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
[TBL] [Abstract][Full Text] [Related]
29. Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival.
Frappier L
Viruses; 2012 Sep; 4(9):1537-1547. PubMed ID: 23170171
[TBL] [Abstract][Full Text] [Related]
30. CK2 and PML: regulating the regulator.
Lallemand-Breitenbach V; de Thé H
Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
[TBL] [Abstract][Full Text] [Related]
31. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
[TBL] [Abstract][Full Text] [Related]
32. Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.
Wang WH; Kuo CW; Chang LK; Hung CC; Chang TH; Liu ST
J Virol; 2015 Sep; 89(17):8922-31. PubMed ID: 26085145
[TBL] [Abstract][Full Text] [Related]
33. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).
Lu F; Wikramasinghe P; Norseen J; Tsai K; Wang P; Showe L; Davuluri RV; Lieberman PM
Virol J; 2010 Oct; 7():262. PubMed ID: 20929547
[TBL] [Abstract][Full Text] [Related]
35. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
[TBL] [Abstract][Full Text] [Related]
36. Role of EBNA1 in NPC tumourigenesis.
Frappier L
Semin Cancer Biol; 2012 Apr; 22(2):154-61. PubMed ID: 22206863
[TBL] [Abstract][Full Text] [Related]
37. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.
Szekely L; Pokrovskaja K; Jiang WQ; de The H; Ringertz N; Klein G
J Virol; 1996 Apr; 70(4):2562-8. PubMed ID: 8642686
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies.
Pennella MA; Liu Y; Woo JL; Kim CA; Berk AJ
J Virol; 2010 Dec; 84(23):12210-25. PubMed ID: 20861261
[TBL] [Abstract][Full Text] [Related]
40. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
Reineke EL; Kao HY
Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
